Halozyme Therapeutics, Inc. (HALO)
A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.
Recs
Could be a bust - or could be a 5 bagger
Recs
Recs
New licensing partnerships and increasing sales of approved products will make this stock a good value in the medium term during uncertain markets.
Recs
This stock seems to truly have a halo around it and should perform nicely as a mover and a shaker. Jump on now to cash in.
Recs
Explosive drug collaboration, $100 million cash, no debt, director just bought 20% of stock, incredible market opportunity, my largest position
Recs
HALO is one of the few stocks I own that I believe will tripple in less than 2 years. Lots of brain power behind this one. Great management, great tech and new relationships with big players will get them there... a lot faster than most would think.
Recs
Stock has taken some hits lately, but poised for growth.
Recs
Many new deals in play, watch this stock, it could double in a few years.
Recs
great technology
Recs
This is an Awesome stock that just keeps increasing! What else can I say?!
Recs
The potential from a $600 Million deal with Roche sounds good to me.
Recs
Just signed a $600 million deal with Roche, a $100+ million deal with Baxter, and has a drug comimg to market in 6 months, there are only 35 employees, production is jobbed out saving capital exp and mfg problems. The only stock I have that could be 20x in 3 years.
Recs
Tons of potential and partnerships already with roche and baxter. Look for more partnerships and revenue to start flowing in...now alot of downside on this stock for the new future.
Recs
Will rule the medical world
Recs
I feel that biotech is an industry of good growth and good profitabillty so i beleave this stock will do good for investors over time!
Recs
Growth company, lots of upside with Baxter and other pharma companies looking to take advantage of your up and coming drugs.
Recs
Again one that i had in the watchlist for a few weeks, should have put it straight into active as it's gone from mid $7 range up to 9+. I like whats happening with this company and the fact that it's got some major players following it and buying it. I wouldn't be suprised though if it makes a bit of a slide sometime soon, the momentum might slow or even reverse, but i'll take what i can from it meantime.
Recs
Cawabonga!!!!
Recs
Product and meeting federal guidelines
Recs
.. betting on it.

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 35 1 2 Next »